McCallMGBreretonTLDawsonA. Frequency of multiple sclerosis in three Australian cities—Perth, Newcastle, and Hobart. J Neurol Neurosurg Psychiatry1968Feb;31(1):1-9.
2.
HammondSRMcLeodJGMillingenKS. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain1988Feb;111(Pt 1):1-25.
3.
McLeodJGHammondSRHallpikeJF. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results. Med J Aust1994Feb7;160(3):117-122.
4.
van der MeiIAPonsonbyALBlizzardL. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology2001Aug;20(3):168-174.
5.
TaylorBVLucasRMDearKKilpatrickTJPenderMPvan der MeiIA. Latitudinal variation in incidence of first central nervous system demyelinating events. Mult Scler2010Apr;16(4):398-405.
6.
van der MeiIAPonsonbyALDwyerT. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ2003Aug9;327(7410):316.
7.
ZivadinovRIonaLMonti-BragadinL. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology2003Jan;22(1):65-74.
8.
Koch-HenriksenNSorensenPS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol2010May;9(5):520-532.
9.
La MantiaLIlleniMTMilaneseC. HLA antigens in Italian multiple sclerosis patients. Ital J Neurol Sci1991;12:81-86.
10.
MarrosuMGMuntoniFMurruMR. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology1988Nov;38(11):1749-1753.
